Skip to content
Screener

Viatris VTRS EPS (Basic)

EPS (Basic) at other companies

Pfizer logo
PfizerPFE
-$0.04-108%
McKesson logo
McKessonMCK
$5.17-17.7%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$1.09+195%
Cencora logo
CencoraCOR
$3.95+11.3%
AMP
Amphastar PharmaceuticalsAMPH
$0.69+4.5%
Aquestive Therapeutics, Inc. logo
Aquestive Therapeutics, Inc.AQST
-$0.07+70.8%

Other financials

Income statement

See full
Revenue$3.8B+4.9%
Gross profit$1.5B+9.3%
Operating income$6.3M-97.3%
Net income-$118.8M-2,483%
EPS (diluted)-$0.10

Balance sheet

See full
Cash & equivalents$890.0M+56.7%
Total debt$13.6B-7.7%
Total equity$14.3B-8.4%
Total assets$35.0B-8.8%

Cash flow

See full
Operating cash flow$381.8M+73.8%
CapEx$52.8M-0.2%
Free cash flow$329.0M+97.2%

Valuation

See full
Market cap$18.97B+84.7%
Enterprise value$31.71B+29.6%
P/S1.3×+0.6×

Profitability

See full
Gross margin34.8%-1.8pp
Operating margin-0.6%
Net margin-2.8%-1.3pp
FCF margin13.3%+0.9pp

Returns & leverage

See full
Return on equity-2.8%-1.3pp
Debt / equity0.0×
Current ratio1.6×+0.2×

Where this comes from

Reported directly by Viatris in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareBasic.

The source filing: Viatris’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:04 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001792044-26-000041
Line itemThree Months Ended / June 30, 2026Three Months Ended / June 30, 2025Six Months Ended / June 30, 2026Six Months Ended / June 30, 2025
Income tax provision (benefit)54.8(212.5)(368.9)(267.5)
Net (loss) earnings$(118.8)$(4.6)$57.6$(3,046.6)
(Loss) earnings per share attributable to Viatris Inc. shareholders
Basic$(0.10)$0.05$(2.58)
Diluted$(0.10)$0.05$(2.58)
Weighted average shares outstanding:
Basic1,163.31,173.01,159.41,182.7
Diluted1,163.31,173.01,173.81,182.7

ITEM 6. [Exhibits](#i61e5533529bd4b8b8b580f5cad6a41ec_190) [74](#i61e5533529bd4b8b8b580f5cad6a41ec_190)

FAQ

What is Viatris's EPS (basic)?
Viatris (VTRS) reported EPS (basic) of -$0.10 in Q2 2026.
What is the long-term trend for Viatris's EPS (basic)?
Over 3 years (2021 to 2025), Viatris's EPS (basic) has grown at a 41.3% compound annual growth rate (CAGR), from -$1.05 to -$2.96.
What does EPS (basic) mean?
Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.

Ask your AI about Viatris's eps (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude